Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Ann Biomed Eng. 2018 Oct 8;47(1):257–271. doi: 10.1007/s10439-018-02146-4

Figure 5.

Figure 5.

Nanoparticle concentration (as a percent of initial amount) within tumor tissue after injection, for each level of tissue heterogeneity at the various IC50-based drug strength values.